Connect with us

Press Releases

Vestar Capital Partners to Make Majority Investment in PetHonesty

Terms of the transaction were not disclosed.

mm

Published

on

(PRESS RELEASE) NEW YORK – Vestar Capital Partners, a leading U.S. middle-market private equity firm, announced that it has agreed to make a majority investment in PetHonesty (or “the Company”), a trusted leader in premium pet health products providing high-quality, innovative pet supplements. PetHonesty co-founders Ben and Camille Arneberg will retain a significant minority stake in the company, and Mr. Arneberg will continue to serve as CEO. Terms of the transaction were not disclosed.

Founded in 2018, PetHonesty is a highly differentiated brand known for its strong focus on product innovation and premium ingredients backed by nutritional science. PetHonesty’s products are formulated to help address a range of common pet ailments, including mobility, digestion, and allergies, providing a healthy supplement to traditional pet diets. Based in Austin, TX, with a second office in New York City, the Company sells its products direct to consumers via its website as well as through partners such as Amazon and Chewy.

Meet 28 of the Coolest Store Cats
Photo Gallery

Meet 28 of the Coolest Store Cats

See What Was Inside the March Sample Box!
PETS+ Sample Box

See What Was Inside the March Sample Box!

PETS+ Presents: Best in Cat Products for 2024!
Photo Gallery

PETS+ Presents: Best in Cat Products for 2024!

“PetHonesty is a fast-growing company that has built a passionate following of pet-loving consumers, and we’re excited to partner with Ben and the entire team as the Company builds on its success,” said Winston Song, managing director and co-head of consumer at Vestar. “Pet parents have shown they are deeply committed to purchasing premium products, and PetHonesty is well positioned as the pet humanization trend and pet ownership continues to grow. We look forward to leveraging our consumer and pet category experience to help PetHonesty expand its brand and reach new customers.”

“Our vision was to create the most trusted pet health company that empowers pet owners to offer their pets healthier and higher quality lives, and our partnership with Vestar is the next step in that journey,” said Mr. Arneberg. “We have been fortunate to find the right partner in Vestar, which remains committed to our business strategy and will help provide the financial backing, industry relationships and category expertise needed to build on our momentum.”

In conjunction with Vestar’s investment, Jeffrey Ansell, a Vestar Senior Advisor and 35+ year consumer industry veteran, will join the PetHonesty board as chairman. Earlier in his career, Mr. Ansell was a Procter & Gamble (“P&G”) executive for 25 years, the last seven of those as president of the Iams company, following P&G’s $2.3 billion acquisition in 1999. During his tenure leading P&G Pet Care, sales of iconic brands Iams and Eukanuba more than doubled from under $800 million to over $1.6 billion, and Iams became the #1 pet nutrition brand in the U.S. Mr. Ansell currently serves as chairman, or member of the Board, for several other Vestar portfolio companies.

Vestar has deep experience in pet food and the broader better-for-you (BFY) food industry. The firm previously owned Big Heart Pet Brands, whose products include Meow Mix, Milk-Bone and Natural Balance. Some of Vestar’s current BFY food investments include Dr. Praeger’s Sensible Foods, a manufacturer of better-for-you plant-based foods; Simple Mills, an innovative, market-leading better-for-you cracker, cookie and baking mix brand in the natural and organic channel; and Presence Marketing, the leading national sales broker dedicated exclusively to representing natural and organic food, beverage and personal care brands.

Advertisement

Kirkland & Ellis LLP served as legal counsel and William Blair acted as financial advisor to Vestar. Egan Nelson LLP served as legal counsel and Lincoln International acted as financial advisor to PetHonesty.

Advertisement

FEATURED VIDEO

Sponsored by Cogent Solutions Group

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at Trixsyn.com.

Promoted Headlines

Most Popular